Table 3.
Adverse events
| Adverse events | Grade < 3, n (%) | Grades 3 or 4, n (%) |
|---|---|---|
| White blood cells decreased | 1 (3.3) | 0 |
| Hypotension | 1 (3.3) | 0 |
| Diarrhea | 6 (20) | 0 |
| Anorexia | 1 (3.3) | 0 |
| Nausea | 2 (6.7) | 0 |
| Abdominal distention | 2 (6.7) | 0 |
| Abdominal pain | 1 (3.3) | 0 |
| Anal pain | 1 (3.3) | 0 |
| Constipation | 1 (3.3) | 0 |
| Hemorrhoids | 1 (3.3) | 0 |
| Vomiting | 2 (6.7) | 0 |
| Chills | 2 (6.7) | 0 |
| Fatigue | 5 (16.7) | 0 |
| Fever | 1 (3.3) | 0 |
| Gram negative Bacilli | 1 (3.3) | 0 |
| UTI | 1 (3.3) | 0 |
| Localized shoulder edema | 1 (3.3) | 0 |
| Insomnia | 2 (6.7) | 0 |
| Dizziness | 1 (3.3) | 0 |
| Vaginal discharge | 1 (3.3) | 0 |
| Vulvar infection-herpes | 1 (3.3) | 0 |
| Upper respiratory tract infection | 2 (6.7) | 0 |
| Cough | 1 (3.3) | 0 |
| Dry skin | 3 (10) | 0 |
| Rash | 2 (6.7) | 0 |
| Palmar-plantar erythrodysesthesia syndrome | 1 (3.3) | 0 |
| Skin irritation | 1 (3.3) | 0 |
| Small intestinal obstruction | 0 | 1 (3.3) |
| Colitis | 0 | 1 (3.3) |
| Acute kidney injury | 0 | 1 (3.3) |